Quick Take
Medical technology company Boston Scientific (BSX) has announced an agreement to acquire aortic valve medical device maker Symetis for $435 million in an all cash transaction.
The global structural heart market is expected to grow rapidly, and Boston Scientific’s acquisition of Symetis promises to take full advantage of that growth opportunity.